APIM Therapeutics
Pharmaceuticals - Ris, Auvergne, France
APIM Therapeutics Employees
APIM Therapeutics Senior Management
APIM Therapeutics Details
APIM Therapeutics is a venture capital financed Norwegian biotech company focusing on the development of novel treatments in the fields of oncology and inflammation. Our lead drug, ATX-101, is a first-in-class peptide drug candidate targeting a novel therapeutic intervention point involved in cellular stress defense mechanisms. ATX-101 is currently being tested in a phase I study in patients with advanced solid tumors.
Website:
http://www.apimtherapeutics.com
Employees:
6
HQ:
Location:
Ris, Auvergne, France
Revenue:
APIM Therapeutics Technologies
Load Balancers
Apache
Fonts
Google Font API
Other
Mobile Friendly